Rxsight Inc (RXST) Stock Price, Quote & News

Company Profile

RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response...

Industry: Medical Devices

Sector: Healthcare

Phone: 949 521 7830

Website: www.rxsight.com

Address:

100 Columbia, Aliso Viejo, United States

RocketThief Jun. 25 at 7:08 PM

$RXST starter - been watching this one a long time

1 · Reply

redbear Jun. 23 at 5:09 PM

$RXST we are rerunning it here again after locking 30%. Saved you 20%. Let's do it again. Starter 2.0

0 · Reply

swingingtech Jun. 18 at 1:54 PM

$ESML $MLTX $RXST $RBBN https://wallstreetwaves.com/projected-growth-esml-could-reach-48/

0 · Reply

FinJay Jun. 6 at 2:11 AM

$RXST https://youtu.be/stgfRqBs1Qs

0 · Reply

TipRanks May. 30 at 10:15 AM

Down Over 30%: Wells Fargo Says Now Is the Time to Load Up on These 2 Beaten-Down Stocks https://www.tipranks.com/news/article/down-over-30-wells-fargo-says-now-is-the-time-to-load-up-on-these-2-beaten-down-stocks $RXST $OMCL

0 · Reply

FinJay May. 27 at 3:45 AM

$RXST https://youtu.be/stgfRqBs1Qs

1 · Reply

redbear May. 20 at 4:28 PM

$RXST fam, we did it, a 30%+ 🚀 ripper on an add lot memorialized into the stocktwits records within days. They have doubted me over 3000 times. Keep the same energy.

1 · Reply

redbear May. 20 at 2:49 PM

$SPY the SPY has a system that has made it the benchmark for a century, it kicks out trash and keeps the winners. I also have a system too. I pick up trash and dump it once it smells better. My system has been better for 15 years. $UNH $REGN $RXST $ENPH

1 · Reply

redbear May. 19 at 5:09 PM

$RXST a 10%+ 🚀 ripper within weeks memorialized into the stocktwits records. Not bad,

0 · Reply

RamenLives May. 19 at 4:40 PM

$RXST Took my profits... very happy...good luck longs!

0 · Reply

RxSight: Valuation Blowout Creates Opportunity

May 20, 2025, 4:10 PM EDT - 5 weeks ago

RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum

May 9, 2025, 7:16 AM EDT - 6 weeks ago

Top 3 Health Care Stocks That Are Preparing To Pump This Quarter

PRTA SRPT

May 7, 2025, 11:04 PM EDT - 7 weeks ago

RxSight, Inc. (RXST) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 4:05 PM EDT - 2 months ago

RxSight, Inc. to Present at the Bank of America Healthcare Conference

Apr 3, 2025, 5:57 PM EDT - 2 months ago

RxSight: Navigating Market Headwinds Amid Intensifying Competition (Downgrade)

Apr 3, 2025, 3:54 PM EDT - 2 months ago

RxSight, Inc. (RXST) Q1 2025 Preliminary Results Conference Call (Transcript)

Apr 2, 2025, 8:00 PM EDT - 3 months ago

RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance

Mar 25, 2025, 4:05 PM EDT - 3 months ago

RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference

Feb 26, 2025, 6:35 AM EST - 4 months ago

RxSight, Inc. (RXST) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 4:05 PM EST - 4 months ago

RxSight, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results, Reaffirms 2025 Guidance

Jan 12, 2025, 9:30 AM EST - 5 months ago

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance

Jan 2, 2025, 4:05 PM EST - 6 months ago

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

Nov 29, 2024, 12:04 PM EST - 7 months ago

RxSight's Momentum In The Large Cataract Surgery Market Merits A Close Eye

Nov 9, 2024, 1:32 PM EST - 8 months ago

RxSight, Inc. (RXST) Q3 2024 Earnings Call Transcript

Oct 24, 2024, 4:05 PM EDT - 8 months ago

RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024

Aug 22, 2024, 4:05 PM EDT - 10 months ago

RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences

Aug 13, 2024, 4:50 PM EDT - 11 months ago

Investing In The Future Of Cataract Surgery: The RxSight Advantage

Aug 5, 2024, 9:45 PM EDT - 11 months ago

RxSight, Inc. (RXST) Q2 2024 Earnings Call Transcript

Aug 5, 2024, 4:05 PM EDT - 11 months ago

RxSight, Inc. Reports Second Quarter 2024 Financial Results

Jul 22, 2024, 4:05 PM EDT - 1 year ago

RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024

Jun 5, 2024, 4:05 PM EDT - 1 year ago

RxSight, Inc. To Participate in the Truist Securities Medtech Conference

May 13, 2024, 4:05 PM EDT - 1 year ago

RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

May 8, 2024, 9:15 PM EDT - 1 year ago

RxSight, Inc. Announces Pricing of Public Offering of Common Stock

May 6, 2024, 10:06 PM EDT - 1 year ago

RxSight, Inc. (RXST) Q1 2024 Earnings Call Transcript

May 6, 2024, 4:05 PM EDT - 1 year ago

RxSight, Inc. Reports First Quarter 2024 Financial Results

Apr 22, 2024, 4:05 PM EDT - 1 year ago

RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024

Apr 4, 2024, 4:05 PM EDT - 1 year ago

RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting

Mar 27, 2024, 4:05 PM EDT - 1 year ago

RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Feb 29, 2024, 7:05 PM EST - 1 year ago

RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference

Feb 28, 2024, 11:44 PM EST - 1 year ago

RxSight, Inc. (RXST) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 4:05 PM EST - 1 year ago

RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 14, 2024, 4:05 PM EST - 1 year ago

RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

Jan 7, 2024, 10:00 AM EST - 1 year ago

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance

Nov 12, 2023, 4:19 AM EST - 1 year ago

RxSight, Inc. (RXST) Q3 2023 Earnings Call Transcript

Nov 2, 2023, 9:00 AM EDT - 1 year ago

RxSight, Inc. Educational and Product Announcements for AAO 2023

Oct 27, 2023, 11:12 AM EDT - 1 year ago

RxSight: Losing Altitude Despite 'Best Of Breed' Platform

Oct 23, 2023, 11:52 AM EDT - 1 year ago

Trading The Top-Performing AI Companies From The Small Cap Universe

INOD IONQ PSCT RGTI

Aug 23, 2023, 4:05 PM EDT - 2 years ago

RxSight, Inc. to Present at the Wells Fargo Healthcare Conference

Aug 7, 2023, 8:56 PM EDT - 2 years ago

RxSight, Inc. (RXST) Q2 2023 Earnings Call Transcript

Aug 7, 2023, 4:05 PM EDT - 2 years ago

RxSight, Inc. Reports Second Quarter 2023 Financial Results

Jul 25, 2023, 4:05 PM EDT - 2 years ago

RxSight, Inc. to Report Second Quarter Financial Results on August 7, 2023

May 13, 2023, 7:14 PM EDT - 2 years ago

RxSight, Inc. (RXST) Q1 2023 Earnings Call Transcript

May 9, 2023, 4:05 PM EDT - 2 years ago

RxSight, Inc. Reports First Quarter 2023 Financial Results

Apr 25, 2023, 4:05 PM EDT - 2 years ago

RxSight, Inc. to Report First Quarter Financial Results on May 9, 2023

$Multiple Surgeon Presentations to Highlight RxSight® Light Adjustable Lens System at Upcoming American Society of Cataract and Refractive Surgery Annual Meeting$

Apr 24, 2023, 4:05 PM EDT - 2 years ago

Multiple Surgeon Presentations to Highlight RxSight® Light Adjustable Lens System at Upcoming American Society of Cataract and Refractive Surgery Annual Meeting

Apr 5, 2023, 4:05 PM EDT - 2 years ago

RxSight, Inc. to Present at the Needham Healthcare Conference

Mar 28, 2023, 12:16 PM EDT - 2 years ago

RxSight: Disrupting The Premium Intraocular Lens Market

Mar 6, 2023, 8:19 PM EST - 2 years ago

RxSight, Inc. (RXST) Q4 2022 Earnings Call Transcript

Mar 6, 2023, 4:05 PM EST - 2 years ago

RxSight, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results

RocketThief Jun. 25 at 7:08 PM

$RXST starter - been watching this one a long time

1 · Reply

redbear Jun. 23 at 5:09 PM

$RXST we are rerunning it here again after locking 30%. Saved you 20%. Let's do it again. Starter 2.0

0 · Reply

swingingtech Jun. 18 at 1:54 PM

$ESML $MLTX $RXST $RBBN https://wallstreetwaves.com/projected-growth-esml-could-reach-48/

0 · Reply

FinJay Jun. 6 at 2:11 AM

$RXST https://youtu.be/stgfRqBs1Qs

0 · Reply

TipRanks May. 30 at 10:15 AM

0 · Reply

FinJay May. 27 at 3:45 AM

$RXST https://youtu.be/stgfRqBs1Qs

1 · Reply

redbear May. 20 at 4:28 PM

$RXST fam, we did it, a 30%+ 🚀 ripper on an add lot memorialized into the stocktwits records within days. They have doubted me over 3000 times. Keep the same energy.

1 · Reply

redbear May. 20 at 2:49 PM

1 · Reply

redbear May. 19 at 5:09 PM

$RXST a 10%+ 🚀 ripper within weeks memorialized into the stocktwits records. Not bad,

0 · Reply

RamenLives May. 19 at 4:40 PM

$RXST Took my profits... very happy...good luck longs!

0 · Reply

redbear May. 19 at 1:53 PM

$RXST we did again fam, another 20%+ 🚀 ripper within days memorialized into stocktwits records

0 · Reply

JarvisFlow May. 19 at 12:00 PM

Wells Fargo has updated their rating for RxSight ( $RXST ) to Overweight with a price target of 25.

0 · Reply

redbear May. 16 at 5:18 PM

$RXST another 10%+ 🚀ripper within days memorialized into the stocktwit records.🙏🏻

1 · Reply

redbear May. 16 at 3:48 PM

$RXST no longer bagholding.

0 · Reply

BryGuy29 May. 14 at 4:52 PM

$RXST $RXST can’t go down forever!!! The non-diffractive IOL tech is great, but cost needs to come down before it goes prime time.

0 · Reply

redbear May. 14 at 2:40 PM

$RXST i’m a bagholder, added.

1 · Reply

BryGuy29 May. 8 at 10:53 PM

$RXST yikes. What a nightmare it is over here. Sell the company!

0 · Reply

leonbnu May. 8 at 2:28 PM

$RXST acting like they just found out the er today...

1 · Reply

BryGuy29 May. 5 at 5:15 PM

$RXST okay I’m back in today. I think we’ve been beaten down enough. Reward>risks at this point.

0 · Reply

redbear May. 3 at 3:08 PM

$RXST ain’t bad, ain’t bad

0 · Reply

GrowthWatcher May. 2 at 10:09 PM

$RXST time to buy

0 · Reply

Horseheels Apr. 29 at 1:48 PM

$RXST

0 · Reply

Market Cap	556.73M
Revenue (ttm)	139.93M
Net Income (ttm)	-27.46M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-19.62%
Debt to Equity Ratio	0.00

Volume	451,700
Avg Vol	936,244
Day's Range	N/A - N/A
Shares Out	40.64M
Stochastic %K	1%
Beta	1.29
Analysts	Sell
Price Target	$21.18